These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8393207)

  • 1. Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain.
    Hannant D; Jessett DM; O'Neill T; Dolby CA; Cook RF; Mumford JA
    Res Vet Sci; 1993 May; 54(3):299-305. PubMed ID: 8393207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
    Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
    Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.
    Mumford JA; Bates J
    Vet Rec; 1984 Apr; 114(15):375-81. PubMed ID: 6328729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One way protection between equid herpesvirus 1 and 4 in vivo.
    Edington N; Bridges CG
    Res Vet Sci; 1990 Mar; 48(2):235-9. PubMed ID: 2159176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of ponies to adjuvanted EHV-1 whole virus vaccine and challenge with virus of the homologous strain.
    Dolby CA; Hannant D; Mumford JA
    Br Vet J; 1995; 151(1):27-37. PubMed ID: 7735868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical signs and humoral immune response in horses following equine herpesvirus type-1 infection and their susceptibility to equine herpesvirus type-4 challenge.
    Stokes A; Corteyn AH; Murray PK
    Res Vet Sci; 1991 Sep; 51(2):141-8. PubMed ID: 1664967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection.
    Kydd JH; Hannant D; Robinson RS; Bryant N; Osterrieder N
    Vaccine; 2020 Jan; 38(2):388-398. PubMed ID: 31629571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes.
    Nordengrahn A; Rusvai M; Merza M; Ekström J; Morein B; Belák S
    Vet Microbiol; 1996 Jul; 51(1-2):55-68. PubMed ID: 8828122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine.
    Wagner B; Goodman LB; Babasyan S; Freer H; Torsteinsdóttir S; Svansson V; Björnsdóttir S; Perkins GA
    Vaccine; 2015 Oct; 33(42):5588-5597. PubMed ID: 26384446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.
    Patel JR; Didlick S; Bateman H
    Equine Vet J; 2004 Jul; 36(5):447-51. PubMed ID: 15253088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
    Perkins G; Babasyan S; Stout AE; Freer H; Rollins A; Wimer CL; Wagner B
    Virology; 2019 May; 531():219-232. PubMed ID: 30928700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens.
    Breathnach CC; Yeargan MR; Sheoran AS; Allen GP
    Equine Vet J; 2001 Nov; 33(7):651-7. PubMed ID: 11770985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses.
    Bürki F; Rossmanith W; Nowotny N; Pallan C; Möstl K; Lussy H
    Vet Q; 1990 Apr; 12(2):80-6. PubMed ID: 2163560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus.
    Burrows R; Goodridge D; Denyer MS
    Vet Rec; 1984 Apr; 114(15):369-74. PubMed ID: 6328728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease.
    Soboll G; Breathnach CC; Kydd JH; Hussey SB; Mealey RM; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):108-117. PubMed ID: 20018383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.